A Phase 4 interventional study of Standard therapy and Maximization of cardiac stroke volume with fluid infusion in Prostate Cancer, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to male participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-10-22.
Sponsored by Rigshospitalet, Denmark · Phase 4, Interventional, and Treatment
The optimal amount of fluid a patient need under surgery is not clear. Both to much and to little fluid can damage the organ functions.
A strategy called "Goal directed therapy", where the fluid amount a patient need is guided by the stroke volume, has shown to minimize post-operative nausea and vomiting.
The investigators intend to investigate if patients treated after these standards, has a better outcome then patients treated after normal regimes, regarding post-operative orthostatic-intolerance.
6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.
This study's enrollment of 44 is below the median of 58 across 4,822 interventional studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Standard therapy
Procedure: Maximization of cardiac stroke volume with fluid infusion
Standard therapy
Maximization of cardiac stroke volume with fluid infusion
To investigate orthostatic cardiovascular response and orthostatic intolerance in patients after removal of the prostate
Time frame: 6 hours
Investigate intraoperative haemodynamics
Time frame: Intraoperative
This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark